Search

everythinglearnresearchcommunity

for

Search:↓

AnnoPharma effectively identifies substances causing adverse drug reactions in medical abstracts.

Hair straightening can damage hair and pose health risks, including exposure to carcinogens and hair loss.

Some psychotropic medications can rarely cause hair loss, and stopping these drugs usually reverses the condition.

Combining PRP and minoxidil improves hair growth and density in treating hair loss.

Micropigmentation is a widely accepted tattooing technique for hiding cosmetic issues and medical uses, with permanent results and few side effects, but risks infection if not done with sterile tools.

Different types of hair loss are linked to COVID-19, with some types possibly increasing risk of getting the virus, while others may be triggered or worsened by the virus.

Combining low-level laser therapy with minoxidil doesn't improve hair loss treatment compared to using minoxidil alone.

Both surgical and non-surgical hair loss treatments lack a standard treatment plan and sufficient patient satisfaction data.

Topical minoxidil effectively and safely treats female pattern hair loss, but other treatments need more research.

Brown Adipose Tissue (BAT) could potentially treat Polycystic Ovary Syndrome (PCOS) by controlling energy balance and lipid homeostasis, but more human research is needed.

More research is needed to confirm if laser therapy effectively treats hair loss.

Stem cell treatments show promise for hair loss but need more research.

Systematic reviews on platelet-rich plasma therapy for hair loss have many quality issues.

Lamivudine might reverse hair graying and needs more research for potential treatments.

Finasteride helps hair growth but may cause sexual side effects.

The study concluded that personalized treatment, including medical and cosmetic approaches, is effective for women with PCOS and hirsutism.

Early surgical treatment for severe facial injuries from high-energy impacts leads to better recovery.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Different types of hair loss need specific treatments, and while many classification systems exist, each has its flaws; more research is needed to refine these systems and treatments.

Hidradenitis suppurativa treatment should be tailored to the individual, with quitting smoking being important.

Drug repositioning is a promising way to quickly develop new treatments, especially for rare diseases.

Finasteride reduces prostate cancer risk but may increase high-grade tumors and has side effects; biopsy methods have similar outcomes; psychosocial factors affect sexual recovery post-surgery.

Eclipta prostrata is a medicinal plant that helps treat diseases, protects the liver and nerves, and promotes hair growth.

Alopecia should be treated as a medical condition because it may increase the risk of serious diseases and psychological issues.

COVID-19 may be linked to hair loss or worsening of hair loss in some people.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

Chronic telogen effluvium may not be a unique condition and could be confused with other types of hair loss.

Nonsteroid treatments for alopecia areata show promise but need more high-quality research.

Dutasteride, fesoterodine, and finasteride help older patients with urinary issues.